2020
Data-Driven Volume Thresholds Predictive of Improved Outcomes after Orthotopic Heart Transplantation
Frankel W, Godfrey E, Suarez E, Rana A, Shafii A, Loor G, Liao K. Data-Driven Volume Thresholds Predictive of Improved Outcomes after Orthotopic Heart Transplantation. The Journal Of Heart And Lung Transplantation 2020, 39: s363. DOI: 10.1016/j.healun.2020.01.441.Peer-Reviewed Original ResearchOrthotopic heart transplantationHigh-volume centersStratum-specific likelihood ratio (SSLR) analysisVolume centersHeart transplantationVolume strataImproved outcomesIntra-aortic balloon pumpImproved early outcomePost-transplant dialysisOrgan Sharing databaseLow-volume centersYears of ageLow-volume counterpartsComplex surgical careHalf of recipientsOHT casesPreoperative characteristicsPostoperative outcomesBalloon pumpFinal cohortPrimary outcomeSharing databaseMedication usageEarly mortality
2019
Characteristics of Elderly Listed for Heart Transplantation: An Analysis of the Scientific Registry of Transplant Recipients
Balakumaran K, Baker W, Tandon V, Joshi S, Tabtabai S, Jaiswal A. Characteristics of Elderly Listed for Heart Transplantation: An Analysis of the Scientific Registry of Transplant Recipients. Journal Of Cardiac Failure 2019, 25: s15. DOI: 10.1016/j.cardfail.2019.07.046.Peer-Reviewed Original ResearchHeart transplantationScientific Registry of Transplant RecipientsNon-elderlyElderly groupElderly patientsProportion of elderly patientsCombined organ transplantationOrthotopic heart transplantationScientific RegistryUNOS Status 1ATransplant recipientsIschemic cardiomyopathyAdult patientsBaseline characteristicsOrgan transplantationStatus 1AElderly candidatesTransplant centersTransplantationPatientsAge groupsProportion of malesMortalityCharacteristics of eldersAgeThe Man with 2 Hearts: 25 Years from Heterotopic to Orthotopic Heart Transplantation
Godfrey E, Kueht M, Rana A, Frazier O. The Man with 2 Hearts: 25 Years from Heterotopic to Orthotopic Heart Transplantation. Texas Heart Institute Journal 2019, 46: 199-202. PMID: 31708703, PMCID: PMC6827470, DOI: 10.14503/thij-17-6544.Peer-Reviewed Original ResearchConceptsHeterotopic heart transplantationHeart transplantationOrthotopic transplantationHeart failureHuman leukocyte antigen mismatchesIntra-aortic balloon pumpIdiopathic nonischemic cardiomyopathyOrthotopic heart transplantationEnd-stage heart failureManagement of end-stage heart failureMechanical circulatory supportCoronary artery stentingAntigen mismatchesNonischemic cardiomyopathyGraft survivalMedical therapyBalloon pumpHeterotopic allograftsCardiac supportArtery stentingMechanical circulatory assist devicesPoor histocompatibilityTransplantationHeart functionNative heart functionInhaled Iloprost Versus Epoprostenol in Heart Transplant Recipients
Enomoto TM, Treggiari MM, Yanez ND, Merkel MJ. Inhaled Iloprost Versus Epoprostenol in Heart Transplant Recipients. Respiratory Care 2019, 64: 743-751. PMID: 30967439, DOI: 10.4187/respcare.06426.Peer-Reviewed Original ResearchConceptsAcute right ventricular dysfunctionHeart transplant recipientsRight ventricular dysfunctionMechanical ventilationEnd pointHeart transplantationHospital stayTransplant recipientsVentricular dysfunctionHemodynamic valuesMedian numberAcute pulmonary hypertensionLength of ICUOrthotopic heart transplantationPrimary end pointSafety end pointSecondary end pointsImmediate postoperative periodPrimary vasodilatorVasoactive medicationsVasodilatory therapyPostoperative bleedingPulmonary hypertensionPostoperative periodConsecutive patients
2014
REDUCED SURVIVAL IN LAMBDA PREDOMINANT CARDIAC AL AMYLOIDOSIS PATIENTS AWAITING ORTHOTOPIC HEART TRANSPLANT
Tabtabai S, Niehaus E, Sarswat N, Stone J, Maurer M, Witteles R, Estep J, Baran D, Zucker M, Feltrin G, Seldin D, Semigran M. REDUCED SURVIVAL IN LAMBDA PREDOMINANT CARDIAC AL AMYLOIDOSIS PATIENTS AWAITING ORTHOTOPIC HEART TRANSPLANT. Journal Of The American College Of Cardiology 2014, 63: a930. DOI: 10.1016/s0735-1097(14)60930-x.Peer-Reviewed Original Research
2013
Frequency of Superior Vena Cava Obstruction in Pediatric Heart Transplant Recipients and Its Relation to Previous Superior Cavopulmonary Anastomosis
Aldoss O, Arain NI, Vinocur JM, Menk J, Ameduri RK, Bryant R, Kochilas LK, Gruenstein DH. Frequency of Superior Vena Cava Obstruction in Pediatric Heart Transplant Recipients and Its Relation to Previous Superior Cavopulmonary Anastomosis. The American Journal Of Cardiology 2013, 112: 286-291. PMID: 23587279, PMCID: PMC6118126, DOI: 10.1016/j.amjcard.2013.03.029.Peer-Reviewed Original ResearchConceptsOrthotopic heart transplantationSuperior vena cava obstructionSVC obstructionVena cava obstructionCavopulmonary anastomosisSuperior cavopulmonary anastomosisCardiac surgeryCava obstructionRisk factorsPediatric heart transplant recipientsPediatric orthotopic heart transplantationSubsequent orthotopic heart transplantationPediatric OHT patientsHeart transplant recipientsPrevious cardiac surgerySignificant risk factorsOHT patientsPosttransplant developmentHeart transplantationTransplant recipientsRetrospective reviewPatientsObstructionSurgeryTransplantationLong-Term Outcomes of Orthotopic Heart Transplantation in Patients with Cardiac Amyloidosis: Differential Survival by Amyloid Type
Yerebakan H, Castano A, Ota T, George I, Hwang L, Jones S, Ryus C, Naroji S, Alvarez J, Naka Y, Takayama H, Maurer M. Long-Term Outcomes of Orthotopic Heart Transplantation in Patients with Cardiac Amyloidosis: Differential Survival by Amyloid Type. The Journal Of Heart And Lung Transplantation 2013, 32: s111. DOI: 10.1016/j.healun.2013.01.231.Peer-Reviewed Original ResearchCardiac amyloidosisCAM patientsHeart transplantationTerm outcomesAL patientsOrthotopic heart transplantationPreoperative serum creatinineLong-term outcomesKaplan-Meier estimatesMean survival timeATTR cardiac amyloidosisLong-term survivalActuarial survivalHospital mortalityTTR patientsCause mortalityPrimary endpointSerum creatinineCell transplantationSystemic diseaseTTR groupsAL amyloidSurvival timeBetter survivalPatients
2008
Pacemaker Therapy for Early and Late Sinus Node Dysfunction in Orthotopic Heart Transplant Recipients: A Single‐Center Experience
LUEBBERT JJ, LEE FA, ROSENFELD LE. Pacemaker Therapy for Early and Late Sinus Node Dysfunction in Orthotopic Heart Transplant Recipients: A Single‐Center Experience. Pacing And Clinical Electrophysiology 2008, 31: 1108-1112. PMID: 18834460, DOI: 10.1111/j.1540-8159.2008.01149.x.Peer-Reviewed Original ResearchConceptsOrthotopic heart transplantationSinus node dysfunctionOHT recipientsEarly complicationsTransplant recipientsLate sinus node dysfunctionSignificant sinus node dysfunctionOrthotopic heart transplant recipientsHeart transplant clinicMean age 50.2Heart transplant recipientsSingle-center experienceAge 50.2Electrophysiology serviceTransplant clinicHeart transplantationHeart transplantPermanent pacemakerLikely multifactorialPacemaker therapyLarge cohortPatientsAmbulatory monitoringRecipientsPacemaker
2000
Right ventricle-sparing heart transplant: promising new technique for recipients with pulmonary hypertension
Elefteriades J, Lovoulos C, Tellides G, Goldstein L, Rocco E, Condos S, Kopf G. Right ventricle-sparing heart transplant: promising new technique for recipients with pulmonary hypertension. The Annals Of Thoracic Surgery 2000, 69: 1858-1863. PMID: 10892937, DOI: 10.1016/s0003-4975(00)01318-7.Peer-Reviewed Original ResearchConceptsRight heart failurePulmonary hypertensionRight heartHeart transplantationHeart failureLeft ventricleOrthotopic heart transplantationSevere pulmonary hypertensionStable sinus rhythmNative aortic valveUnsolved clinical problemPulmonary arterial connectionCardiac transplantationCardiopulmonary bypassArterial connectionsSinus rhythmAortic valveHypertensionClinical problemHeterotopic transplantationTransplantationVentricleEarly causeHeartRecipients
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply